{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:21:47Z","timestamp":1792844507778,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41409-020-0857-x","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T08:02:54Z","timestamp":1584432174000},"page":"1966-1974","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Trajectories of acute graft-versus-host disease and mortality in critically ill allogeneic-hematopoietic stem cell recipients: the Allo-GRRR-OH score"],"prefix":"10.1038","volume":"55","author":[{"given":"Claire","family":"Pichereau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Lenglin\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Valade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4553-3065","authenticated-orcid":false,"given":"David","family":"Michonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Ghrenassia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Lemiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-7533","authenticated-orcid":false,"given":"G\u00e9rard","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"857_CR1","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","volume":"363","author":"TA Gooley","year":"2010","unstructured":"Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363:2091\u2013101.","journal-title":"N Engl J Med"},{"key":"857_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/sj.bmt.1705036","volume":"36","author":"GG Wulf","year":"2005","unstructured":"Wulf GG, Hasenkamp J, Jung W, Chapuy B, Truemper L, Glass B. Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin\u2019s lymphoma. Bone Marrow Transpl. 2005;36:271\u20133.","journal-title":"Bone Marrow Transpl"},{"key":"857_CR3","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jcrc.2015.06.020","volume":"30","author":"D Mokart","year":"2015","unstructured":"Mokart D, Granata A, Crocchiolo R, Sannini A, Chow-Chine L, Brun J-P, et al. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: outcomes of patients admitted to intensive care unit. J Crit Care. 2015;30:1107\u201313.","journal-title":"J Crit Care"},{"key":"857_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3324\/haematol.2016.152900","volume":"102","author":"F Tissot","year":"2017","unstructured":"Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 2017;102:433\u201344.","journal-title":"Haematologica"},{"key":"857_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/bmt.2013.141","volume":"49","author":"R Benz","year":"2014","unstructured":"Benz R, Schanz U, Maggiorini M, Seebach JD, Stussi G. Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transpl. 2014;49:62\u20135.","journal-title":"Bone Marrow Transpl"},{"key":"857_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1200\/JCO.2005.03.9073","volume":"24","author":"F P\u00e8ne","year":"2006","unstructured":"P\u00e8ne F, Aubron C, Azoulay E, Blot F, Thi\u00e9ry G, Raynard B, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol. 2006;24:643\u20139.","journal-title":"J Clin Oncol"},{"key":"857_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/bmt.2010.255","volume":"46","author":"P Depuydt","year":"2011","unstructured":"Depuydt P, Kerre T, Noens L, Nollet J, Offner F, Decruyenaere J, et al. Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience. Bone Marrow Transpl. 2011;46:1186\u201391.","journal-title":"Bone Marrow Transpl"},{"key":"857_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/bmt.2015.55","volume":"50","author":"E Lenglin\u00e9","year":"2015","unstructured":"Lenglin\u00e9 E, Chevret S, Moreau A-S, P\u00e8ne F, Blot F, Bourhis J-H, et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transpl. 2015;50:840\u20135.","journal-title":"Bone Marrow Transpl"},{"key":"857_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/bmt.2015.269","volume":"51","author":"L Platon","year":"2016","unstructured":"Platon L, Amigues L, Ceballos P, Fegueux N, Daubin D, Besnard N, et al. A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009\u20132013). Bone Marrow Transpl. 2016;51:256\u201361.","journal-title":"Bone Marrow Transpl"},{"key":"857_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/bmt.2013.107","volume":"49","author":"T Ruutu","year":"2014","unstructured":"Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A, et al. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transpl. 2014;49:168\u201373.","journal-title":"Bone Marrow Transpl"},{"key":"857_CR11","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1182\/blood-2009-06-204669","volume":"114","author":"G Soci\u00e9","year":"2009","unstructured":"Soci\u00e9 G, Blazar BR. Acute graft-versus-host disease: from the bench to the bedside. Blood. 2009;114:4327\u201336.","journal-title":"Blood"},{"key":"857_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/bjh.13959","volume":"173","author":"J Magenau","year":"2016","unstructured":"Magenau J, Runaas L, Reddy P. Advances in understanding the pathogenesis of graft-versus-host disease. Br J Haematol. 2016;173:190\u2013205.","journal-title":"Br J Haematol"},{"key":"857_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jiac.2016.05.006","volume":"22","author":"U Sahin","year":"2016","unstructured":"Sahin U, Toprak SK, Atilla PA, Atilla E, Demirer T. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2016;22:505\u201314.","journal-title":"J Infect Chemother"},{"key":"857_CR14","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1200\/JCO.2013.50.5867","volume":"31","author":"UD Bayraktar","year":"2013","unstructured":"Bayraktar UD, Shpall EJ, Liu P, Ciurea SO, Rondon G, de Lima M, et al. Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol. 2013;31:4207\u201314.","journal-title":"J Clin Oncol"},{"key":"857_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295\u2013304.","journal-title":"Transplantation"},{"key":"857_CR16","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transpl. 1995;15:825\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"857_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.seminhematol.2005.09.007","volume":"43","author":"NJ Chao","year":"2006","unstructured":"Chao NJ, Chen BJ. Prophylaxis and treatment of acute graft-versus-host disease. Semin Hematol. 2006;43:32\u201341.","journal-title":"Semin Hematol"},{"key":"857_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transpl. 2005;11:945\u201356.","journal-title":"Biol Blood Marrow Transpl"},{"key":"857_CR19","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1164\/rccm.201001-0018OC","volume":"182","author":"E Azoulay","year":"2010","unstructured":"Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med. 2010;182:1038\u201346.","journal-title":"Am J Respir Crit Care Med"},{"key":"857_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/CCM.0b013e31822b50c2","volume":"40","author":"M Legrand","year":"2012","unstructured":"Legrand M, Max A, Peigne V, Mariotte E, Canet E, Debrumetz A, et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med. 2012;40:43\u20139.","journal-title":"Crit Care Med"},{"key":"857_CR21","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"857_CR22","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transpl. 2009;15:1628\u201333.","journal-title":"Biol Blood Marrow Transpl"},{"key":"857_CR23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.7326\/0003-4819-125-8-199610150-00001","volume":"125","author":"GD Rubenfeld","year":"1996","unstructured":"Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med. 1996;125:625\u201333.","journal-title":"Ann Intern Med"},{"key":"857_CR24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1164\/ajrccm.158.3.9711076","volume":"158","author":"KJ Price","year":"1998","unstructured":"Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med. 1998;158:876\u201384.","journal-title":"Am J Respir Crit Care Med"},{"key":"857_CR25","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41409-018-0181-x","volume":"53","author":"C Saillard","year":"2018","unstructured":"Saillard C, Darmon M, Bisbal M, Sannini A, Chow-Chine L, Faucher M, et al. Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality. Bone Marrow Transpl. 2018;53:1233\u201341.","journal-title":"Bone Marrow Transpl"},{"key":"857_CR26","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/bjh.12294","volume":"161","author":"WM Townsend","year":"2013","unstructured":"Townsend WM, Holroyd A, Pearce R, Mackinnon S, Naik P, Goldstone AH, et al. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol. 2013;161:578\u201386.","journal-title":"Br J Haematol"},{"key":"857_CR27","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","volume":"31","author":"E Azoulay","year":"2013","unstructured":"Azoulay E, Mokart D, P\u00e8ne F, Lambert J, Kouatchet A, Mayaux J, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium-a groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique study. J Clin Oncol. 2013;31:2810\u20138.","journal-title":"J Clin Oncol"},{"key":"857_CR28","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1200\/JCO.2016.66.9549","volume":"34","author":"M Soares","year":"2016","unstructured":"Soares M, Bozza FA, Azevedo LCP, Silva UVA, Corr\u00eaa TD, Colombari F, et al. Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care units. J Clin Oncol. 2016;34:3315\u201324.","journal-title":"J Clin Oncol"},{"key":"857_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/jamaoncol.2015.3336","volume":"2","author":"MG Shrime","year":"2016","unstructured":"Shrime MG, Ferket BS, Scott DJ, Lee J, Barragan-Bradford D, Pollard T, et al. Time-limited trials of intensive care for critically ill patients with cancer: how long is long enough? JAMA Oncol. 2016;2:76\u201383.","journal-title":"JAMA Oncol"},{"key":"857_CR30","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s00134-017-4884-z","volume":"43","author":"E Azoulay","year":"2017","unstructured":"Azoulay E, Schellongowski P, Darmon M, Bauer PR, Benoit D, Depuydt P, et al. The intensive care medicine research agenda on critically ill oncology and hematology patients. Intensive Care Med. 2017;43:1366\u201382.","journal-title":"Intensive Care Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-020-0857-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-020-0857-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-020-0857-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:17:58Z","timestamp":1684617478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-020-0857-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1038\/s41409-020-0857-x","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"23 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}